Alerta De Seguridad para CytoSorb 300 mL Device

Según Department of Health, este evento ( alerta de seguridad ) involucró a un dispositivo médico en Hong Kong que fue producido por CytoSorbents.

¿Qué es esto?

Las alertas proporcionan información importante y recomendaciones sobre los productos. Aunque se haya emitido una alerta, esto no significa necesariamente que el producto se considera peligroso. Las alertas de seguridad, dirigidas a trabajadores de la salud y a usuarios, pueden incluir retiro de equipos. Pueden ser escritas por los fabricantes, pero también por funcionarios del área de salud.

Más información acerca de la data acá
  • Tipo de evento
    Safety alert
  • Fecha
    2016-01-12
  • Fecha de publicación del evento
    2016-01-12
  • País del evento
  • Fuente del evento
    DH
  • URL de la fuente del evento
  • Notas / Alertas
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • Notas adicionales en la data
    Medical Device Safety Alert
  • Causa
    Medical device safety alert: cytosorbents cytosorb 300 ml device the medicines and healthcare products regulatory agency (mhra) of united kingdom posted a medical device safety alert concerning cytosorb 300 ml device manufactured by cytosorbents. the manufacturer has identified a possible incompatibility of the cytosorb 300 ml device with the inhaled anaesthetic gas, nitrous oxide (n2o). this combination has been associated with the death of three pigs in animal studies using the cytosorb 300 ml device for an intended purpose for which it is not yet ce marked. to the manufacturer’s knowledge, there have been no such reported cases of adverse events relating to the combination of the cytosorb 300 ml device with n2o in treatment of humans. the manufacturer advises clinicians not to use cytosorb in combination with n2o under any circumstances until further notification from the manufacturer. the clinical scenario described is likely to be most relevant for patients that are undergoing surgery using n2o, which is relatively rare in modern surgical anaesthesia. for details, please refer to the mhra website:https://www.Gov.Uk/drug-device-alerts/field-safety-notices-4-january-to-8-january-2016 if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 12 january 2016.

Device

  • Modelo / Serial
  • Descripción del producto
    Medical Device Safety Alert: CytoSorbents CytoSorb 300 mL Device
  • Manufacturer

Manufacturer